This is a strong insider conviction buy from a major shareholder. Traders should watch for upcoming catalysts (e.g., pipeline updates, partnership news) that may have prompted the accumulation. The sustained buying pattern suggests confidence in near-term value.
ARTV drugs
ARTV drug pipeline →How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 3 $10.76entry
- T+1 · 4mo ago +2.88%α +1.08% · $11.07
- T+5 · 3mo ago +4.28%α +2.25% · $11.22
- T+20 · 3mo ago +5.02%α +3.78% · $11.30
- T+60 · 21d ago −60.36%α −62.14% · $4.27
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
RA Capital Management, L.P., a director and 10% owner, purchased $2.05M of ARTV shares in four open-market transactions over eight days (July 22-29, 2026). This represents ~0.79% of the $258M market cap and is a strong insider conviction signal, especially given the firm's sustained buying pattern ($5.0M total insider purchases in the last 30 days).
Key Financial Metrics
Key Facts
- RA Capital Management (Director, 10% Owner) bought $2.05M of ARTV shares across 4 trades at ~$9.93-$9.99 per share.
- Total insider purchases in the last 30 days reached $5.0M across 10 transactions.
- Purchase represents ~0.79% of ARTV's $258M market cap, a significant proportional stake.
- Analyst consensus is 92% bullish (4 Strong Buy, 7 Buy, 1 Hold).
Financial Impact
Insider purchase of $2.05M (0.79% of market cap) by a 10% owner.
Risk Factors
- No specific corporate catalyst disclosed; the buy may reflect long-term positioning rather than imminent news.
- Biotech sector volatility and clinical-stage risk remain.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001231919-26-000817 |
Track record
33 reports on ARTV
10 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +66.32% at T+60 after the Jun 8, 2026 report. 16 of 18 went positive at some point.
Filters
- Nov 9, 20267d ago 8-K/A Bearish 7/10 Entry $4.06 Now $3.96 +2.46% settles Dec 9
- Nov 3, 202613d ago Insider Cluster Bearish 6/10 Entry $4.22 Now $3.96 +6.16% settles Dec 3
- Oct 27, 202620d ago 8-K Bearish 6/10 Entry $4.27 Now $3.96 +7.26% settles Nov 24
- Oct 6, 20265w ago 144 Neutral 3/10 Entry $7.00 to $4.21 Now $3.96 −43.43% ▼ −39.93% −38.69% vs SPY
- Sep 11, 20269w ago 8-K Neutral 3/10 Entry $10.14 to $6.77 Now $3.96 −60.95% ▼ −33.23% −35.50% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
- Sep 9, 20269w ago Insider Cluster Bearish 5/10 Entry $10.42 to $6.80 Now $3.96 +62.00% ▲ +34.74% +37.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers